<DOC>
	<DOCNO>NCT00536393</DOCNO>
	<brief_summary>Interest use pegylated liposomal doxorubicin ( ca√©lyx )</brief_summary>
	<brief_title>Treatment Disseminated High Grade Lymphoma</brief_title>
	<detailed_description>R CHOP good standard treatment diffuse high grade lymphoma . Howeverin elderly patient often toxic , specially haematologic cardiac toxicity .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<criteria>high grade lymphoma disseminate &gt; 60 year old &lt; 75 informed consent sign cardiac state compatible antracyclin ECOG &lt; /= 2 patient &gt; 75 year old Cardiac insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2007</verification_date>
	<keyword>diffuse larg cell lymphoma</keyword>
	<keyword>chemotherapy</keyword>
	<keyword>toxicity</keyword>
	<keyword>diffuse high grade lymphoma</keyword>
</DOC>